| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | 7.5M | $60.1M | 0.0% | 7.556% | 0.63% |
| 5 | BlackRock, Inc. | 5.3M | $42.5M | +6.0% | 5.349% | 0.00% |
| 6 | Tyro Capital Management LLC | 4.5M | $35.7M | +50.2% | 4.491% | 8.01% |
| 7 | Aberdeen Group plc | 4.2M | $33.4M | +1.4% | 4.200% | 0.05% |
| 8 | SR ONE CAPITAL MANAGEMENT, LP | 4.0M | $32.1M | 0.0% | 4.041% | 3.09% |
| 9 | STATE STREET CORP | 3.7M | $29.9M | +2.4% | 3.757% | 0.00% |
| 10 | Capital World Investors | 2.8M | $22.1M | — | 2.774% | 0.00% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $20.5M | +0.4% | 2.571% | 0.00% |
| 12 | MILLENNIUM MANAGEMENT LLC | 2.5M | $20.2M | -57.9% | 2.539% | 0.01% |
| 13 | UBS Group AG | 1.9M | $15.5M | -14.2% | 1.953% | 0.00% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $13.6M | +11.3% | 1.711% | 0.00% |
| 15 | BOOTHBAY FUND MANAGEMENT, LLC | 1.6M | $12.8M | +539.1% | 1.613% | 0.17% |
| 16 | GENERAL AMERICAN INVESTORS CO INC | 1.1M | $9.1M | +55.8% | 1.141% | 0.54% |
| 17 | Third Point LLC | 1.0M | $8.0M | 0.0% | 1.007% | 0.17% |
| 18 | PEREGRINE CAPITAL MANAGEMENT LLC | 672K | $5.4M | — | 0.677% | 0.17% |
| 19 | Tejara Capital Ltd | 607K | $4.9M | +188.5% | 0.611% | 2.00% |
| 20 | ADAR1 Capital Management, LLC | 601K | $4.8M | -55.9% | 0.605% | 0.22% |
| 21 | Pavaki Capital Management LLC | 580K | $4.6M | — | 0.584% | 0.70% |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | 567K | $4.5M | +11.0% | 0.571% | 0.00% |
| 23 | CITADEL ADVISORS LLC | 567K | $4.5M | -69.2% | 0.571% | 0.00% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551K | $4.4M | +3.4% | 0.555% | 0.00% |
| 25 | NORTHERN TRUST CORP | 549K | $4.4M | +3.7% | 0.553% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in SPRY — a direct measure of their conviction.
| 76.51% |
| +4.26 pp |
| $927M |
| +25% |
| Q4 2024 | 162 | +10% | 72.25% | +5.84 pp | $741M | 19% |
| Q3 2024 | 147 | — | 66.41% | — | $912M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
34 institutions opened new positions in SPRY during Q2 2026, while 31 fully exited. 70 added to existing positions and 91 trimmed.
SPRY institutional ownership fell by 2.93 percentage points quarter-over-quarter, with a net change of +3 holders.
The top 10 institutions account for 67.4% of all reported 13F value in SPRY, and the top 25 account for 86.8%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.